Company · CIK 0001321834 · SIC 2835 — In Vitro & In Vivo Diagnostic Substances · Nasdaq
Q/C TECHNOLOGIES, INC. · QCLS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2018 AForm 4 → | Jan 2, 2019, 5:00 pm EST | Howard YeatonCEO, CFO | 7,500 | $1.27 | $9,525 | 7,500 | — | plan? |
| Oct 17, 2017 AForm 4/A → | Apr 10, 2018, 8:42 pm EDT | John J GormallyChief Executive Officer, Director | 150,000 | $0.88 | $132,000 | 180,000 | — | plan? |
| Oct 17, 2017 AForm 4 → | Oct 24, 4:54 pm EDT | Gary M RauchVP - Finance, Treasurer | 36,277 | $0.88 | $31,924 | 63,777 | — | plan? late |
| Oct 17, 2017 GForm 4 → | Oct 24, 4:50 pm EDT | John J GormallyChief Executive Officer, Director | 150,000 | $0.88 | $132,000 | 180,000 | — | plan? late amended |
| Sep 2, 2016 GForm 5 → | Feb 13, 2017, 5:35 pm EST | Brandon Thomas KnoxDirector | 13,750 | — | — | 124,326 | — | plan? |
| Jun 8, 2016 AForm 4/A → | Apr 10, 2018, 8:40 pm EDT | John J GormallyChief Executive Officer, Director | 27,500 | $1.99 | $54,725 | 30,000 | — | plan? |
| Jun 8, 2016 GForm 4 → | Jun 14, 7:00 am EDT | John J GormallyChief Executive Officer | 27,500 | $1.99 | $54,725 | 30,000 | — | plan? late amended |
| May 24, 2016 PForm 4 → | May 24, 5:57 pm EDT | John J GormallyChief Executive Officer | 2,500 | $2.23 | $5,567 | 2,500 | — | plan? |
| Jan 5, 2016 PForm 4 → | Jan 6, 6:02 am EST | Raymond Francis Akers Jr.Executive Chairman, Secretary, Director | 2,100 | $1.34 | $2,814 | 72,100 | +3.00% | plan? |
| Dec 30, 2015 AForm 4 → | Jan 5, 2016, 2:03 pm EST | Thomas J KnoxDirector | 70,000 | — | — | 478,150 | — | plan? late |
| Dec 30, 2015 AForm 4 → | Dec 31, 3:43 pm EST | Brandon Thomas KnoxDirector | 55,000 | — | — | 138,076 | — | plan? |
| Dec 30, 2015 AForm 4 → | Dec 31, 12:12 pm EST | Gary M RauchVP - Finance, Treasurer | 22,500 | — | — | 27,500 | — | plan? |
| Dec 30, 2015 AForm 4 → | Dec 31, 12:10 pm EST | Robert E AndrewsDirector | 48,125 | — | — | 48,125 | — | plan? |
| Dec 30, 2015 AForm 4 → | Dec 31, 12:06 pm EST | Raza BokhariDirector | 32,083 | — | — | 32,083 | — | plan? |
| Dec 11, 2015 PForm 4 → | Dec 14, 4:16 pm EST | Gary M RauchVP - Finance, Treasurer | 3,500 | $1.50 | $5,250 | 5,000 | +233% | plan? |
| Jan 9, 2015 AForm 4/A → | Jan 5, 2016, 2:06 pm EST | Thomas J KnoxDirector | 50,000 | — | — | 408,150 | — | plan? |
| Jan 9, 2015 AForm 4 → | Jan 12, 6:08 pm EST | Gavin MoranDirector | 35,000 | — | — | 35,000 | — | plan? |
| Jan 9, 2015 AGForm 4 → | Jan 12, 6:07 pm EST | Raymond Francis Akers Jr.Executive Chairman, Secretary, Director | 140,000 | — | — | 70,000 | — | plan? |
| Jan 9, 2015 AForm 4 → | Jan 12, 6:03 pm EST | Thomas J KnoxDirector | 50,000 | — | — | 466,666 | — | plan? amended |
| Jan 1, 2015 AForm 4 → | Jan 12, 6:03 pm EST | Brandon Thomas KnoxDirector | 35,000 | — | — | 83,076 | — | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 12, 2015 GForm 4 → | Jan 12, 6:07 pm EST | Raymond Francis Akers Jr.Executive Chairman, Secretary, Director | 40,000 | — | — | 40,000 | — |